Stryker Corporation
NYQ: SYKLive Quote
📈 ZcoreAI Score
Our AI model analyzes Stryker Corporation's price action across multiple timeframes using regression channels and statistical scoring.
Get SYK Z-Score →About Stryker Corporation
Healthcare
Medical Devices
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
📊 Fundamental Analysis
Stryker Corporation demonstrates a healthy profit margin of 12.9%.
The company recently reported 11.4% revenue growth, which is above average for the Healthcare sector.
Return on Equity (ROE) is 15.1%, which suggests room for improvement in capital utilization.
At a current price of $339.15, SYK currently sits at the 23rd percentile of its 52-week range (Range: $319.32 - $404.87).
💰 Valuation Insight
SYK trades at a 61.3% premium to the sector average PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
⚠️
Profit Margin
Moderate
🔴
Debt/Equity
Elevated
⚠️
Revenue Growth
Moderate
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$129.89B
Trailing P/E
40.33
Forward P/E
20.27
Beta (5Y)
0.93
52W High
$404.87
52W Low
$319.32
Avg Volume
2.07M
Day High
Day Low